Wapnick Pamela Insider Trades

Insider Trading History

Track insider trading activity for Wapnick Pamela. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Metagenomi
Metagenomi MGX
Chief Financial Officer
Holding Value $281k 211,375 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 168,000 shares
$1.34
$1.33
Metagenomi
Metagenomi MGX
Chief Financial Officer
Holding Value $249k 187,375 shares
Last Trade
Mar 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.53k 1,581 shares
$1.60
$1.33
Metagenomi
Metagenomi MGX
Chief Financial Officer
Holding Value $251k 188,956 shares
Last Trade
Dec 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.79k 1,576 shares
$1.77
$1.33
Metagenomi
Metagenomi MGX
Chief Financial Officer
Holding Value $253k 190,532 shares
Last Trade
Dec 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$192k 120,000 shares
$1.60
$1.33
Metagenomi
Metagenomi MGX
Chief Financial Officer
Holding Value $93.8k 70,532 shares
Last Trade
Sep 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.85k 1,576 shares
$1.81
$1.33
Metagenomi
Metagenomi MGX
Chief Financial Officer
Holding Value $95.9k 72,108 shares
Last Trade
Jun 06, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.76k 1,576 shares
$1.75
$1.33
Metagenomi
Metagenomi MGX
Chief Financial Officer
Holding Value $112k 84,000 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 84,000 shares
$1.32
$1.33

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up